Pharma — India Trade-secret Cases
3 decisions indexed
Page 1 of 1 · 3 total
SaNotize Research and Development v.Lupin Limited
The court permitted the plaintiff to amend their plaint, specifically regarding the separation of pure copyright material into a new exhibit. Given the sensitive nature of both parties' confidential information, the court ordered a controlled inspection meeting between limited representatives of both sides to facilitate further proceedings.
Genentech Inc And Others v.Drugs Controller General Of India And Others
This case involves an application by Defendant No. 3 seeking to restrict the participation of the plaintiffs' internal expert, Dr. Samir Sagitrao, in the inspection of confidential clinical and pre-clinical test data related to a biosimilar drug. The court ultimately dismissed the applicant's request, emphasizing that defendants have a right to defend the suit without being deprived of opportunity due to non-disclosure.
K.L. Chaturvedi v.State Of Madhya Pradesh And Ors.
The petitioner challenged the constitutionality of the Drugs Act, 1940, arguing that the amendment requiring mandatory disclosure of the true formula or ingredient list for his proprietary medicine 'Germs Killer' would expose his trade secret. The court upheld the amended provisions, finding them reasonable and necessary for public health and safety.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.